The research hub for one rare gene




We fund the research that will treat SLC35A2-CDG, a disease no company is working on.


Every euro buys a named result with a date. Written deliverables, a timeline and ownership terms, agreed with every lab before any payment.


Started by one family in Helsinki. Built for every child with this gene.
Fewer than 100 cases published · Fifteen families in contact · The first project funded by the founding family